3 not yet recruiting, 1 enrolling by invitation. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Not yet recruiting 3, Enrolling by invitation 1 |
Follow sintilimab: new trials by email Literature Review of sintilimab trials Research Report on sintilimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Genotype-Driven Neoadjuvant Therapy for Locally Advanced Thyroid Cancer: A Real-World Cohort Study Dabrafenib, Trametinib, Selpercatinib - Thyroid Neoplasms | Phase 4 | Not yet recruiting | Fujian Medical University | 335 | 2025-07-01 | 2025-06-08 |
| Intestinal Microbiota Transplantation, Radiochemotherapy and Sintilimab in Localized Advanced Colon Cancer Sintilimab plus Chemotherapy, Intestinal microbiota capsules, Standard Long Course Radiotherapy - Localized Advanced Rectal Adenocarcinoma | Phase 4 | Enrolling by invitation | First Affiliated Hospital of Ningbo University | 20 | 2025-03-01 | 2025-04-17 |
| BV in the Treatment of Relapsed/refractory Hodgkin Lymphoma Brentuximab Vedotin (Bv), Sintilimab, Tislelizumab - Hodgkin Lymphoma (Category) | Phase 4 | Not yet recruiting | Xiuhua Sun | 100 | 2024-12-31 | 2025-01-07 |
| Clinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric Cancer Irinotecan Hydrochloride Liposome Injection - Gastric Cancer | Phase 4 | Not yet recruiting | First Affiliated Hospital Xi'an Jiaotong University | 44 | 2024-07-15 | 2024-07-12 |
Hodgkin Disease (1) · Recurrence (1) · Stomach Neoplasms (1) · Thyroid Neoplasms (1)
First Affiliated Hospital Xi'an Jiaotong University (1) · First Affiliated Hospital of Ningbo University (1) · Fujian Medical University (1) · Xiuhua Sun (1)
China (3)